PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiovascular Research Institute, Loyola University Chicago, Health Sciences Division, Maywood, IL, USA.\', \'Campbell University College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC, USA.\', \'Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.\', \'AbbVie Inc., North Chicago, IL, USA.\', \'Ligocki Dental Group, Oak Brook, IL, USA.\', \'Bahcesehir University, Istanbul, Turkey.\', \'Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Thrombosis Center, Service D\'Hématologie Biologique Hôpital Tenon, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/10760296211056648
?:hasPublicationType
?:journal
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
is ?:pmid of
?:pmid
?:pmid
  • 35167393
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35167393>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35167393>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all